- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Bajaj Healthcare Ivejaj gets DCGI nod for COVID treatment
The drug will be available as a prescription-based medication, with recommended doses.
Thane: Bajaj Healthcare Limited (BHL) has recently announced the launch of "Ivejaj" (Ivermectin) an AntiParasitic Drug now widely used in control & treatment for Covid-19 patients. BHL has received approval from India's drug regulator, to manufacture and market "Ivejaj" the oral Ivermectin approved medication in India for the treatment of COVID-19.IVEJAJ Tablets comprising...
Thane: Bajaj Healthcare Limited (BHL) has recently announced the launch of "Ivejaj" (Ivermectin) an AntiParasitic Drug now widely used in control & treatment for Covid-19 patients.
BHL has received approval from India's drug regulator, to manufacture and market "Ivejaj" the oral Ivermectin approved medication in India for the treatment of COVID-19.
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751